£6.27m
+51%vs Mar 2024Active10124700Private limited companyBirmingham
XEAL PHARMA LTD
Significant control: Haidar Abdullah Mohammed Al-Bukhari (significant control), Ibraar Mahmood Sultan (significant control) and 2 more
From public filings as at 31 Aug 2026; may contain errors or be out of date. Verify at Companies House · Terms
Watch this company
Get an email when Companies House records a change for Xeal Pharma Ltd: status, filings, accounts, officers or owners. Free.
Not live yet: alerts start by 15 December 2026. We store your email and this company number only, for these alerts. If alerts don’t launch, we tell you and delete your address. Privacy
Coming soon · product and service lists
What does Xeal Pharma Ltd sell?
Registered activity: Manufacture of basic pharmaceutical products (SIC 21100). We’re building product and service lists for UK companies. Get this one when it’s ready.
One email, only about this. If we don’t launch within 60 days we’ll tell you. Privacy
01
Summary
XEAL PHARMA LTD is an active private limited company (company number 10124700) incorporated on 14 April 2016, registered in Birmingham. Its registered activity is manufacture of basic pharmaceutical products (SIC 21100). Latest small accounts cover the period ending 31 March 2025, showing net assets of £6.27m and cash of £1.16m, with 93 employees on average. Net assets rose 51% on the prior period (£4.16m).
Peer position · net assets
By net assets it sits in the top quarter of 661 comparable companies in the UK (median £265, upper quartile £89k).
02
Ownership and control
- Mr Haidar Abdullah Mohammed Al-Bukhari
- has significant influence or control
- Mr Ibraar Mahmood Sultan
- has significant influence or control
- Mr Husam Amer Hisham Jafar
- has significant influence or control
- Mr Azhar-Zafeer Chughtai
- has significant influence or control
Persons with significant control hold 25% or more of shares or voting rights. Smaller shareholdings are only listed in confirmation-statement documents. Directors and secretaries: see the officers list at Companies House.
03
Key dates
- Incorporated
- 14 April 201610 yrs ago
- Next accounts due
- 31 December 2026in 68 days
- Confirmation statement due
- 28 April 2027in 186 days
Due dates are expected from Companies House filing rules; confirm on the official register before relying on them.
04
Activity
- SIC 21100
- Manufacture of basic pharmaceutical products
- Accounts type
- Total Exemption Full
- Size band
- SmallCompanies Act thresholds
05
Financials
£1.16m
+19%vs Mar 2024Not reported
93
+90%vs Mar 2024| Period end | Net assets | Cash | Debtors | Creditors <1y | Turnover | Profit | Employees |
|---|---|---|---|---|---|---|---|
| 31 March 2025 | £6.27m | £1.16m | £5.35m | — | — | — | 93 |
| 31 March 2024 | £4.16m | £974k | £2.33m | — | — | — | 49 |
Cash per employee£12kCash ÷ average employees
Figures as filed in iXBRL accounts at Companies House. "—" means the line was not reported in that filing.
06
Filing and accounts signals
- Net assets above zeroNet assets £6,273,957 at 31 March 2025
- Net assets up 10% or more on the prior period+50.8% vs prior period
- Cash at bank of £50,000 or moreCash £1,158,305
- Incorporated five or more years agoIncorporated 14 April 2016
Neutral facts read from the register and filed accounts, each with its evidence. They are not a rating, a prediction or advice, and may be incomplete or out of date. How each signal is derived.
07
Timeline
- Confirmation statement duein 186 days
- Next accounts duein 68 days
- Accounts period endNet assets £6.27m · small accounts
- Accounts period endNet assets £4.16m · small accounts
- Incorporated
08
Similar companies in Birmingham
- BETTER CALL PAUL LIMITEDBirmingham · inc. May 2016
- BIOAVEXIA LTDBirmingham · inc. Jun 2016
- VITABONNA DEVELOPMENT LIMITEDBirmingham · inc. Jan 2017
- WAVE LIFE SCIENCES UK LIMITEDBirmingham · inc. Apr 2017
- CAMBCOL LTDBirmingham · inc. Dec 2014
- PENTONOVA LIMITEDBirmingham · inc. Jul 2014
All companies incorporated on 14 April 2016 · in Apr 2016.
09
Reminders for XEAL PHARMA LTD
Get an email before each filing deadline — accounts and confirmation statement — so nothing is late.